Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.
Home »
NDTV News - India-news
» Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
No comments:
Post a Comment